Bio-Techne (TECH) Curent Deferred Tax Liability (2012 - 2013)
Bio-Techne's (TECH) quarterly Curent Deferred Tax Liability came in at $9.9 million in Q2 2013, down 30.14% year-on-year from $14.2 million in Q2 2012, and down 1.23% quarter-over-quarter from $10.1 million in Q1 2013.
Bio-Techne (TECH) Curent Deferred Tax Liability (2012 - 2013) Analysis & Trends
Bio-Techne's Curent Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $9.9 million for Q2 2013.
- On a quarterly basis, Curent Deferred Tax Liability fell 30.14% year-over-year to $9.9 million in Q2 2013; TTM through Jun 2013 was $9.9 million, a 30.14% decrease from a year earlier, with the FY2013 full-year figure at $9.9 million, down 30.14% from the prior year.
- Curent Deferred Tax Liability slipped to $9.9 million in Q2 2013 per TECH's latest filing, from $10.1 million in the prior quarter.
- Across five years, Curent Deferred Tax Liability topped out at $14.2 million in Q2 2012 and bottomed at $4.2 million in Q4 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 9.94 Mn |
| Jun 30, 2013 | 9.94 Mn |
| Mar 31, 2013 | 10.07 Mn |
| Mar 31, 2013 | 10.07 Mn |
| Dec 31, 2012 | 4.21 Mn |
| Dec 31, 2012 | 4.21 Mn |
| Sep 30, 2012 | 6.17 Mn |
| Sep 30, 2012 | 6.17 Mn |
| Jun 30, 2012 | 14.23 Mn |
| Jun 30, 2012 | 14.23 Mn |
| Mar 31, 2012 | 4.26 Mn |
| Mar 31, 2012 | 4.26 Mn |